Publicaciones en colaboración con investigadores/as de Centre Hospitalier Universitaire de Liège (30)

2024

  1. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study

    Journal of Cystic Fibrosis, Vol. 23, Núm. 5, pp. 815-822

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. Inter-center reproducibility of standard and advanced echocardiographic parameters in the EACVI-AFib echo registry

    Echocardiography, Vol. 40, Núm. 8, pp. 775-783

  5. Multimodality imaging for patient selection, procedural guidance, and follow-up of transcatheter interventions for structural heart disease: a consensus document of the EACVI Task Force on Interventional Cardiovascular Imaging: part 1: access routes, transcatheter aortic valve implantation, and transcatheter mitral valve interventions

    European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 9, pp. e209-e268

  6. Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 85-96

2022

  1. Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry

    European Journal of Heart Failure, Vol. 24, Núm. 7, pp. 1253-1265

  2. Correction to: Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry (Infection, (2022), 50, 5, (1191-1202), 10.1007/s15010-022-01792-0)

    Infection

  3. European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease

    European Heart Journal Open, Vol. 2, Núm. 5

  4. Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry

    Infection, Vol. 50, Núm. 5, pp. 1191-1202

2021

  1. Anticoagulation in patients with atrial fibrillation and active cancer: An international survey on patient management

    European Journal of Preventive Cardiology, Vol. 28, Núm. 6, pp. 611-621

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  3. The structural heart disease interventional imager rationale, skills and training: a position paper of the European Association of Cardiovascular Imaging

    European Heart Journal Cardiovascular Imaging, Vol. 22, Núm. 5, pp. 471-479

2020

  1. Age-specific reference values for carotid arterial stiffness estimated by ultrasonic wall tracking

    Journal of Human Hypertension, Vol. 34, Núm. 3, pp. 214-222

  2. Correction: Age-specific reference values for carotid arterial stiffness estimated by ultrasonic wall tracking (Journal of Human Hypertension, (2020), 34, 3, (214-222), 10.1038/s41371-019-0228-5)

    Journal of Human Hypertension

  3. Correlation between non-invasive myocardial work indices and main parameters of systolic and diastolic function: Results from the EACVI NORRE study

    European Heart Journal Cardiovascular Imaging, Vol. 21, Núm. 5, pp. 533-541

  4. Echocardiographic reference ranges for normal left ventricular layer-specific strain: Results from the EACVI NORRE study

    European Heart Journal Cardiovascular Imaging, Vol. 21, Núm. 8, pp. 896-905

  5. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

    Annals of Oncology, Vol. 31, Núm. 2, pp. 171-190

  6. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)

    European Journal of Heart Failure, Vol. 22, Núm. 9, pp. 1504-1524